Modulating the immune response in demyelinating diseases.
Hughes
R
R
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D003711:Demyelinating Diseases / Q000097:blood / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology / Q000627:therapeutic use*; D010951:Plasma Exchange / Q000379:methods*; D011129:Polyradiculoneuropathy / Q000097:blood / Q000628:therapy*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism
D000276:Adjuvants, Immunologic; D016756:Immunoglobulins, Intravenous; D016212:Transforming Growth Factor beta